Fig. 2From: Tumor-targeting, Systemically Delivered Antisense HER-2 Chemosensitizes Human Breast Cancer Xenografts Irrespective of HER-2 LevelsComparison of AS HER-2 ODN uptake mediated by F-Lip-2 versus Lipofectin or free ODN in MDA-MB-435 FF cells. Transfection with Lipofectin was performed as described in the manufacturer’s protocol.Back to article page